Popular Articles

Jan 01, 2012
Pharmaceutical Executive
It's a disturbing irony: In an industry whose entire economic value is founded on its ability to innovate, why is there so much discomfort with the risk required for innovation. Where did the courage to innovate go?
Dec 01, 2011
Pharmaceutical Executive
It's a neck and neck race toward safer, faster, and medically superior treatments. Which organizations have what it takes to jockey their products into the winner's circle?
Sep 01, 2011
Pharmaceutical Executive
Despite the gloom, most forecasts show the US will stay atop the industry in profits for at least the next generation of products.
Sep 01, 2011
Pharmaceutical Executive
Especially when payers come to the table holding the best cards — leaving industry second-guessing its strategy.
Sep 01, 2011
Pharmaceutical Executive
The time is right for industry to overcome its social media phobia once and for all.
Jul 01, 2011
Pharmaceutical Executive
Taking Onyx Pharmaceuticals to new heights – CEO Tony Coles talks to PharmExec about the midsize company's transition from adolescence to adulthood.
Jul 01, 2011
Pharmaceutical Executive
'Like' and 'Dislike' practices in the virtual Facebook pharmaceutical world.
Jul 01, 2011
Pharmaceutical Executive
EAB Member Al Topin delivers 10 questions that should drive your brand-building marketing program.
Jul 01, 2011
Pharmaceutical Executive
What India's latest census tells us about current and future pharma opportunities.
May 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
A factory tour to examine Merck's automated robots—and the human minds that inspire them
native1_300x100
lorem ipsum